Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:3079-3085
Published online before print May 28, 2007, doi: 10.1161/CIRCULATIONAHA.106.652842
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
115/24/3079    most recent
CIRCULATIONAHA.106.652842v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, D.
Right arrow Articles by Mitchell, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, D.
Right arrow Articles by Mitchell, G. F.
Related Collections
Right arrow Epidemiology
Right arrow Other hypertension
Right arrow Peripheral vascular disease
Right arrow Other Research
Right arrow Other diagnostic testing

(Circulation. 2007;115:3079-3085.)
© 2007 American Heart Association, Inc.


Epidemiology

Associations of Plasma Natriuretic Peptide, Adrenomedullin, and Homocysteine Levels With Alterations in Arterial Stiffness

The Framingham Heart Study

Daniel Levy, MD; Shih-Jen Hwang, PhD; Atilla Kayalar, MD; Emelia J. Benjamin, MD, MSc; Ramachandran S. Vasan, MD; Helen Parise, ScD; Martin G. Larson, ScD; Thomas J. Wang, MD; Jacob Selhub, PhD; Paul F. Jacques, ScD; Joseph A. Vita, MD; Michelle J. Keyes, MA; Gary F. Mitchell, MD

From the NHLBI Framingham Heart Study, Framingham, Mass (D.L., S.-J.H., E.J.B., R.S.V., T.J.W., M.G.L., M.J.K.); the National Heart, Lung, and Blood Institute, Bethesda, Md (D.L., S.-J.H.); Department of Medicine, MetroWest Medical Center, Framingham, Mass (A.K.); Division of Cardiology, Massachusetts General Hospital, Boston, Mass (T.J.W.), Jean Mayer USDA Human Nutrition Research Center on Aging and Friedman School of Nutrition Science and Policy, Tufts University, Boston, Mass (J.S., P.F.J.); Departments of Mathematics and Statistics, Boston University, Boston, Mass (H.P., M.G.L.); Cardiology Section (D.L., E.J.B., R.S.V., J.A.V.) and Preventive Medicine and Epidemiology (E.J.B., R.S.V., M.G.L., D.L.), Boston University School of Medicine, Boston, Mass; and Cardiovascular Engineering, Inc, Waltham, Mass (G.F.M.).

Correspondence to Daniel Levy, MD, 73 Mt Wayte Ave, Ste 2, Framingham, MA 01702.

Received July 18, 2006; accepted April 3, 2007.

Background— Increased arterial stiffness and higher plasma natriuretic peptide and homocysteine levels are associated with elevated risk for cardiovascular disease. Little is known about the relations of natriuretic peptides and homocysteine to arterial wall stiffness in the community.

Methods and Results— We assessed the relations of plasma N-terminal atrial natriuretic peptide, B-type natriuretic peptide, adrenomedullin, and homocysteine concentrations to arterial stiffness in participants in the Framingham Heart Study. Central pulse pressure, forward pressure wave, reflected pressure wave, carotid-femoral pulse wave velocity, and carotid-radial pulse wave velocity were assessed by tonometry in 1962 participants (mean age, 61 years; 56% women) in the Framingham Heart Study. Central systolic and diastolic blood pressures were 123/75 mm Hg in men and 119/66 mm Hg in women. After adjustment for age and clinical covariates, N-terminal atrial natriuretic peptide and B-type natriuretic peptide were associated with carotid-femoral pulse wave velocity (men: partial correlation, 0.069, P=0.043 and r=0.115, P≤0.001, respectively; women: r=–0.063, P=0.037 and r=–0.062, P=0.040), and carotid-radial pulse wave velocity (men: r=–0.090, P=0.009 and r=–0.083, P≤0.015; women: r=–0.140, P≤0.001 and r=-0.104, P=0.001, respectively). In men, N-terminal atrial natriuretic peptide and B-type natriuretic peptide also were associated with forward and reflected wave and carotid pulse pressure. In men, adrenomedullin was associated with mean arterial pressure (r=0.089, P=0.009), and homocysteine was associated with carotid-femoral pulse wave velocity (r=0.072, P=0.036), forward pressure (r=0.079, P=0.02), and central pulse pressure (r=0.072, P=0.035). Interaction tests indicated sex differences in the relations of several biomarkers to measures of arterial stiffness.

Conclusions— Plasma natriuretic peptide, adrenomedullin, and homocysteine levels are associated with alterations in conduit vessel properties that differ in men and women.


 

CLINICAL PERSPECTIVE